30- Pemphigoid group Flashcards
(45 cards)
which atoantibodies is bullous pemphigoid associated with?
BP 180 (transmembrane protein) BP 230 (cytoplasmic protein belonging to the plakin family)
- almost all patients with BP ahave circulating IgG autoantibodies that bind to BP180.
Which domain region of BP180 do the IgG autoantibodies in bullous pemphigoid bind to?
- the NC16A domain.
which domain of the BP230 region does the IgG in bullous pempghiod bind to?
C terminal region.
What autoantigens are found in gestational pemphigoid?
- BP 180 and 230
What autoantigens are found in mucous membrane pemphigoid?
BP 180
BP 230
Laminin 332, Laminin 311 and Integrin B4
What autoantigens are found in linear IgA?
- LAD antigen
- BP 180
- BP 230
- Type VII collagen
what autoantigens are found in epidermolysis bullosa acquisita?
type VII collagen
What autoantigens are found in bullous systemic lupus erythematousus?
type VII collagen
what are the clinical features of bullous pemphigoid?
Non bullous pemphigoid:
- polymphoorphic, non specific featres
- mid to severe intractable pruritis
Bullous phase:
- development of vesicles and bullae on normal or erythematous skin + urticated plaques.
- blisters may be blood tinged.
- in 10-30% of patients may have oral cavity involvement.
what diseases are associated with bullous pemphigoid?
- rarely Inflammatory bowel disease
- Hashitmoto thryoiditis
- rheumatoid arthritis
- dermatomyositis
- lupus erythematosus
what is the epitope spreading phenomenon?
- chronic inflammatory process at the dermal-epidermal junction which results in exposure of antigens to autoreactive T lymphocytes which leads to a secondary immune response.
What neurological disorders is BP associated with/
Parkinson disease, dementia, psychiatric disordrs like bipolar and unipolar disorders, stroke.
Multiple sclerosis.
What drugs are implicated in bullous pemphigoid?
- diuretics
- NSAIDs
- antibiotics
- ACE inhibitors
- TNF inhibitors
- checkpoint inhibitors like pembrolizuma.
what are the histological features of bullous pemphigoid?
- subepidermal blister
- dermal inflammatory infiltrate with eosinophils in th uppdr dermis
- net of fibrin
What are the features of direct immunoflurescence microscopy of BP
- linear deposits of IgG +/- C3 along the basement membraane
Ig1 and Ig4 are the predominant subclasses.
n-serrated pattern
salt split skin: deposits at the roof
What linear fluorescence pattern is seen at the basement membrane zone?
n serrated: bullous pemphigoid and linear IgA.
u serated: epidermolysis bullosa acquisita.
What are some differential diagnosis of prebullous pemphigoid.
- drug reaction
urticaria
arthropod reaction
scabies.
what are the differential diagnosis of bullous pemphigoid?
- EBA
- linear IgA
- mucous membrane pemphigoid
- pemphigoid incipiens
- anti-p200 pemphigoids (neutrophils rather than eosinophils)
the presence of the which four clinical criteria strongly indicate a diagnosis of BP (in patients with subepidermal blistering)
- absence of mucosal involvement
- absence of skin atrophy
- absence of head and neck involvement
- age greater than70
what is the prognosis of bullous pemphigoid?
- 30% of patients have a relase in the first year
- if therapy ceased then a relapse occurs within the first 3 months.
- death rate is between 10 - 40%
how is BP monitored
- can be monitored by looking at the BP180 ELISA.
levels at day 0,60 and 150 appear to predict disease relapse (small decrease btween day 0 and 60 is associated with a relapse).
What treatment options are available for mild and/or localized BP?
- superpotent topical steroids
- oral pred
- doxy+ nicotinamide (500 - 2000 mg/day)
- eryrhyomycin, penicilins
- dapsone
- topical immunomodulators
What treatment options are available for severe bullous pemphigoid? (extensive disease > 10 blisters or inflammatory lesions/day)
- superpotent topical steroids
- oral pred 0.5-1 mg/kg /day
- AZA
- MMF (1.5 - 3 g/day)
- MTX (7.5 mg-15 mg/week)
- chlorambucil
- IVIg
- Rituximab
- Omalizumab
How long to patients with bullous pempigoid need to be treated for?
6 -12 monts (unless steroid-resistant)